BioCatalystWatch
ALGSWorkspace / ALGS / OverviewCompany library
Aligos Therapeutics, Inc. logo

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. (ALGS)

Website

Price
Market cap
Next catalystQ4 2026, following completion of the 150 mg MAD cohortALG-170675 · Trial initiationSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

pevifoscorvir sodium (ALG-000184)

HBV capsid

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

pevifoscorvir sodium (ALG-000184)

HBV capsid

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

ALG-097558

Coronavirus 3CLpro

PreINDP1P2P3FilingApproved
ALG-097558

Coronavirus 3CLpro

PreINDP1P2P3FilingApproved
ALG-097558

Coronavirus 3CLpro

PreINDP1P2P3FilingApproved
ALG-097558

Coronavirus 3CLpro

PreINDP1P2P3FilingApproved
ALG-055009

THR-β

ALG-055009

THR-β

PreINDP1P2P3FilingApproved
ALG-055009

THR-β

PreINDP1P2P3FilingApproved
ALG-000111

HBeAg × HBV core protein (HBc)

PreINDP1P2P3FilingApproved
ALG-005398

HBV core protein (HBc)

PreINDP1P2P3FilingApproved

Partner / License out

ALG-170675

HBV X-region RNA × TLR8

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

History / paused

HBsAg-expression host factors

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ALGS PR & News

PR & News

ALGS SEC archive